As new mutations of SARS-CoV-2 keep spreading worldwide, Hyris keeps monitoring its test kits effectiveness, performing routine analysis of SARS-CoV-2 variants to safeguard public health and the product's quality by assessing the potential impact of new strains on sensitivity and specificity.

U.S. Manufacturer has ramped up production of Viral Transport Media to support COVID testing and tracing in the U.S. and Canada

Sier Capital Partners is excited to announce it is supporting the management team of Integrated Laboratory Systems (ILS) in an acquisition of the company.

BillionToOne's unique testing protocol removes costly, time-consuming step of RNA extraction and significantly expands testing capacity